Malgorzata A.
- Country
- Poland
- Department
- NA
Research Overview
- Phase III Study of RO7795068 for Weight Management in Adults With Obesity or Overweight Without Type 2 Diabetes
- Efficacy and safety of zenagamtide versus semaglutide in participants with overweight or obesity and type 2 diabetes
- Pan-European proof-of-concept study comparing Decentralised Clinical Trial (DCT) and hybrid approaches to conventional clinical trial approaches in patients with Type 2 diabetes mellitus treated with Toujeo®
Data & Insights
Has run more than one trial at 81 of 374 partner sites.
Specializations
Diabetes Management Innovation
This investigator specializes in advancing Type 2 diabetes mellitus (T2DM) treatment through innovative therapeutic approaches, particularly focusing on novel insulin delivery systems and combination therapies.
- Weekly insulin administration protocols
- Insulin combination therapies
- Blood glucose control optimization
Their work encompasses evaluating cutting-edge treatments including insulin icodec and combination products for enhanced glycemic management.
Digital Health Integration
The investigator explores decentralized clinical trial methodologies in diabetes care, investigating technology-centered approaches to improve patient engagement and research outcomes.
- Remote patient monitoring
- Digital health platforms
- Patient-centric trial design
Their research evaluates the effectiveness of hybrid and decentralized trial models in improving participant experience and data collection.
Metabolic Disorders
The investigator's expertise extends to treating metabolic disorders, with particular emphasis on the intersection of obesity and diabetes management.
- Novel therapeutic agents
- Weight management interventions
- Comparative treatment efficacy
Their research includes evaluation of innovative compounds for managing obesity and metabolic conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.